Teva Pharmaceutical Industries (TEVA +1.0%) is voluntarily recalling
fourteen lots of metformin hydrochloride extended-release tablets due
to the detection of N-nitrosodimethylamine (NDMA) levels in excess of
the Acceptable Daily Intake Limit (ADI).
NDMA is an environmental contaminant and considered a probable human carcinogen based on lab tests.
https://seekingalpha.com/news/3580881-teva-recalls-lots-of-metformin-due-to-contamination
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.